This presentation discusses what types of mergers between small equals work best, which ones actually improve the market position of the combined company, and how to manage and redefine the company in the aftermath of such a merger. A discussion is presented on how a small biotech company can survive through a merger of a major pharmaceutical partner. This is a time when many merged companies reassess their alliance portfolio and small start-ups risk losing their primary source of revenue and their credibility in financial markets. Presentations from both the start-up and the big pharma perspectives are made. Identify yourself as a Cambridge Healthtech Institute conference attendee to receive the reduced room rate.
Rooms are limited, so please book early.
Travel Information Special Airline Discounts Available Special zone and discount fares have been established on United Airlines for this conference. A - Z October 29 th 30 th Tremont House Boston, Massachusetts.